Drug Profile
Influenza virus vaccine injectable/intranasal - ID Biomedical
Alternative Names: SPD 701Latest Information Update: 19 Nov 2007
Price :
$50
*
At a glance
- Originator ID Biomedical Corporation
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 08 Dec 2005 ID Biomedical Corporation has been acquired by GlaxoSmithKline
- 29 Sep 2004 Phase-I clinical trials in Influenza virus infections in Canada (Injection)
- 29 Sep 2004 Phase-I clinical trials in Influenza virus infections in Canada (Intranasal)